| 2026-09-01 | Press release | Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals |
| 2026-08-13 | Press release | Bio-Techne Corrects Dividend Announcement |
| 2026-08-12 | Press release | Bio-Techne Declares Dividend |
| 2026-08-12 | Press release | Bio-Techne Releases Fourth Quarter Fiscal 2026 Results |
| 2026-07-08 | Press release | Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio |
| 2026-06-25 | Press release | Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sci |
| 2026-06-04 | Press release | Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization |
| 2026-05-06 | Press release | Bio-Techne Declares Dividend |
| 2026-05-06 | Press release | Bio-Techne Releases Third Quarter Fiscal 2026 Results |
| 2026-05-06 | Press release | Earnings Release |
| 2026-05-06 | Press release | PDF: Bio-Techne Releases Third Quarter Fiscal 2026 Results |
| 2026-05-06 | Press release | PDF |
| 2026-05-04 | Press release | Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference |
| 2026-04-16 | Press release | Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarit |
| 2026-04-14 | Press release | Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results |
| 2026-03-25 | Press release | Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite |
| 2026-02-24 | Press release | Bio-Techne to Present at Upcoming Investor Conferences |
| 2026-02-16 | Press release | Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for Euro |
| 2026-02-11 | Press release | Bio-Techne Announces Changes to its Leadership Team |
| 2026-02-04 | Press release | Bio-Techne Declares Dividend |
| 2026-02-04 | Press release | Bio-Techne Releases Second Quarter Fiscal 2026 Results |
| 2026-02-04 | Press release | Earnings Release |
| 2026-02-04 | Press release | PDF: Bio-Techne Releases Second Quarter Fiscal 2026 Results |
| 2026-02-02 | Press release | Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative |
| 2026-01-28 | Press release | Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurologi |
| 2026-01-20 | Press release | Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results |
| 2026-01-01 | Presentation | View Presentation |
| 2025-11-05 | Press release | PDF: Bio-Techne Releases First Quarter Fiscal 2026 Results |
| 2025-08-06 | Press release | Earnings Release |
| 2025-08-06 | Press release | PDF: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results |
| 2025-06-30 | Press release | Earnings Release |
| 2025-06-03 | Presentation | Presentation |
| 2025-05-07 | Press release | PDF: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS |
| 2025-02-05 | Press release | Earnings Release |
| 2025-02-05 | Press release | PDF: Bio-Techne Releases Second Quarter Fiscal 2025 Results |
| 2024-10-30 | Press release | HTML |
| 2024-10-30 | Press release | PDF: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS |
| 2024-08-07 | Press release | PDF: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS |
| 2024-06-04 | Presentation | Presentation |
| 2024-05-01 | Press release | HTML |